Asha Nayak
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab + Poly-ICLC in MRP Colon Cancer (NCT02834052) | Asha Nayak | 2018-01-10 |
| Pembrolizumab + Idelalisib for Lung Cancer Study (NCT03257722) | Asha Nayak | 2017-09-26 |
Track Asha Nayak automatically
Every clearance here is in the API, with alerts when new ones post.